Publication:
Potential role of tyrosine kinase inhibitors during primary HIV-1 infection

Simple item page
dc.contributor.authorAmbrosioni, Juan
dc.contributor.authorCoiras, Mayte
dc.contributor.authorAlcamí, José
dc.contributor.authorMiró, José María
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderRed de Investigación Cooperativa en Investigación en Sida (España)
dc.date.accessioned2019-02-12T14:54:10Z
dc.date.available2019-02-12T14:54:10Z
dc.date.issued2017
dc.description.sponsorshipThis work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2013-44677-R, SAF2016-78480-R); the Instituto de Salud Carlos III (ISCIII-FIS PI16CIII/00034); and the Spanish AIDS Research Network RD16CIII/0002/0001-ISCIII-FEDER. JAM developed this work in the frame of a ‘Juan de la Cierva 2012’ post-doctoral program, Ministerio de Competitividad, Spain. JMM received a personal intensification research grant #INT15/00168 during 2016 from Instituto de Salud Carlos III, Madrid, Spain.es_ES
dc.format.number5es_ES
dc.format.page421-423es_ES
dc.format.volume15es_ES
dc.identifier.citationExpert Rev Anti Infect Ther. 2017 May;15(5):421-423.es_ES
dc.identifier.doi10.1080/14787210.2017.1308823es_ES
dc.identifier.e-issn1744-8336es_ES
dc.identifier.issn1478-7210es_ES
dc.identifier.journalExpert review of anti-infective therapyes_ES
dc.identifier.pubmedID28322065es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7170
dc.language.isoenges_ES
dc.publisherTaylor & Francis
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2013-44677-Res_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2016-78480-Res_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI16CIII/00034es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD16CIII/0002/0001es_ES
dc.relation.publisherversionhttps://doi.org/10.1080/14787210.2017.1308823es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectHIVes_ES
dc.subjectTKIes_ES
dc.subjectTyrosine kinase inhibitorses_ES
dc.subjectAcute/recent infectiones_ES
dc.subjectDasatinibes_ES
dc.subjectPrimary infectiones_ES
dc.subjectViral reservoirses_ES
dc.subject.meshAnti-HIV Agentses_ES
dc.subject.meshAntiretroviral Therapy, Highly Activees_ES
dc.subject.meshCD4-Positive T-Lymphocyteses_ES
dc.subject.meshDasatinibes_ES
dc.subject.meshGene Expression Regulationes_ES
dc.subject.meshHIV Infectionses_ES
dc.subject.meshHIV-1es_ES
dc.subject.meshHumanses_ES
dc.subject.meshLymphocyte Activationes_ES
dc.subject.meshPhosphorylationes_ES
dc.subject.meshProtein Kinase Inhibitorses_ES
dc.subject.meshProtein-Tyrosine Kinaseses_ES
dc.titlePotential role of tyrosine kinase inhibitors during primary HIV-1 infectiones_ES
dc.typeeditoriales_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationf729e106-ee5d-450a-b046-63b14e24c1a3
relation.isAuthorOfPublication2fc55aca-54b0-411c-b170-c2149068a902
relation.isAuthorOfPublication.latestForDiscoveryf729e106-ee5d-450a-b046-63b14e24c1a3
relation.isFunderOfPublication77b2fc20-6311-4e46-98a7-83e46257b93b
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublication.latestForDiscovery77b2fc20-6311-4e46-98a7-83e46257b93b
relation.isPublisherOfPublicationaf7833ee-b4f1-4914-9339-d65cbe8472b9
relation.isPublisherOfPublication.latestForDiscoveryaf7833ee-b4f1-4914-9339-d65cbe8472b9

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PotentialRoleOfTyrosine_2017.pdf
Size:
572.1 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Centro Nacional de Microbiología (CNM)